<DOC>
	<DOCNO>NCT02981173</DOCNO>
	<brief_summary>The purpose study investigate effect oral psilocybin pulse regimen chronic cluster headache . Subjects randomize receive oral placebo , low dose psilocybin , high dose psilocybin three experimental session , separate 5 day . Subjects maintain headache diary prior , , pulse regimen order document headache frequency intensity , , pulse regimen .</brief_summary>
	<brief_title>Psilocybin Chronic Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<mesh_term>Psilocybine</mesh_term>
	<criteria>Chronic cluster headache At least one attack daily Attacks respond highflow oxygen Axis I psychotic disorder ( e.g . schizophrenia , bipolar I , depression psychosis ) Axis I psychotic disorder first degree relative Concomitant diagnosis migraine headache Unstable medical condition , severe renal , cardiac hepatic disease , pacemaker , serious central nervous system pathology Pregnant , breastfeeding , lack adequate birth control History intolerance psilocybin , lysergic acid diethylamide ( LSD ) , related compound drug alcohol abuse within past 3 month ( exclude tobacco ) Urine toxicology positive drug abuse Use vasoconstrictive medication ( i.e . sumatriptan , pseudoephedrine , midodrine ) past two week Use antidepressant medication ( i.e . amitriptyline , isocarboxazid , fluoxetine , citalopram ) past 6 week Use steroid certain immunomodulatory agent ( i.e . azathioprine ) past 2 week</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>